Gastrointestinal tolerability of once‐weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
Sean Wharton, Salvatore Calanna, Melanie Jane Davies, Dror Dicker, Bryan Goldman, Ildiko Lingvay, Ofri Mosenzon, Domenica Rubino, Mette Thomsen, Thomas A. Wadden, Sue D. Pedersen
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1111/dom.14551
- Published
- Sep 13, 2021
- Venue
- Diabetes Obesity and Metabolism
- DOI
- 10.1111/dom.14551
- PubMed
- 34514682
- Categories
- Pharmacology and Obesity Treatment
- License
- cc-by-nc
- Provenance
- openalex